chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Nuchal rigidity, Tinnitus, Vertigo
Clinical narrative: Chronic severe head ache (uncommon), rigidity of neck,  earache, dizziness , fullness of the head,  tinnitus both ears more loud left side like very loud crickets sound. As time progressed now May 6, 2021 I am  experiencing the same symptoms plus vertigo at night and loss of hearing  in both ears.  My insurance does not cover the big copay for doctor's visit
Age: 20.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Back pain, Chills, Decreased appetite, Dizziness
Clinical narrative: All after second injection: Fever of 100.8. Went down to 99.8 after 4 hours. Took Tylenol to help. Headache 3 hours after second dose, has not gone away. Pain at the injection site, 2 hours after, has not gone away. Chills that started 12 hours after injection. Loss of appetite after 20 hours of injection. Back pain/body aches 8 hours after injection.  Some dizziness on and off starting 20 hours after injection.  Feeling weak 20 hours after injection.
Age: 20.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Injection site pain, Pain, Pyrexia
Clinical narrative: All after second injection: Fever of 100.8. Went down to 99.8 after 4 hours. Took Tylenol to help. Headache 3 hours after second dose, has not gone away. Pain at the injection site, 2 hours after, has not gone away. Chills that started 12 hours after injection. Loss of appetite after 20 hours of injection. Back pain/body aches 8 hours after injection.  Some dizziness on and off starting 20 hours after injection.  Feeling weak 20 hours after injection.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Pruritus, Tremor
Clinical narrative: About 15 minutes after receiving the vaccine, the patient reported itching. Patient reported whole body itching and hands were shaking. Patient was given 10ml of liquid Benadryl and EMS was called. EMS arrived on-site. Patient was still itching. EMS requested second dose of liquid Benadryl and advised patient to go to hospital. Patient refused to go with EMS, instead called mother to pick her up. Patient confirmed she also has anxiety.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysphonia, Dyspnoea, Erythema, Throat tightness
Clinical narrative: Approx 12:25pm, patient received Pfizer Covid vaccine, assessed by RN at 12:26pm, 12:30pm patient complained of throat tightness, 12:31 patient complained of voice being raspy.  Radial HR 120, pupils equal and reactive.  Denies nausea.  No hives/rash noted.  At that time, patient admitted to previously being diagnosed with Paradoxal Reactions to Medications, Anxiety and Depression.  Patient takes Zoloft and Elavil, and admits to being anxious. 12:40-12:43pm patient states that she is feeling SOA,  throat tightness, dizziness.  Respiration unlabored, however patient admits to becoming more anxious.  Patient red faced, HR 130's.  12:44pm Epinephrine 0.1mg/0.15mg/0.3mg auto injector given IM to right outer thigh.  Patient tolerated well. EMS called at 12:45pm.  EMS arrived to assess patient at 12:53pm.  Patient walked into ambulance.  Patient did not require O2.  No hives noted.  Denies nausea.  Patient transported to ER per protocol for evaluation.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever between 99 and 102 degrees for 5 days
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient received the 2nd Moderna dose 3 days early. No adverse events.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Dysphagia, Fatigue, Oropharyngeal pain
Clinical narrative: Extreme fatigue from 8-10 am (one week to the day after shot one) followed by severe throat pain while swallowing for the rest of the day. Throat pain did not last more than 24 hours.  Low throat pain while drinking water. Pain while eating or drinking anything else (tea, OJ, eggs, an apple) felt like I was swallowing fiberglass.
Age: 83.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Diarrhoea, Fatigue, Feeling abnormal, Headache
Clinical narrative: Vomiting (4), Diarrhea (6), headache, shaking, slight fever, rash blotches down my arm, red and sore vaccination site, fatigue (slept 36 hours), brain fog, no energy, continued nausea.
Age: 83.0
Sex: F
Vaccine: VARZOS
Symptoms: Hypersomnia, Injection site erythema, Nausea, Pyrexia, Rash
Clinical narrative: Vomiting (4), Diarrhea (6), headache, shaking, slight fever, rash blotches down my arm, red and sore vaccination site, fatigue (slept 36 hours), brain fog, no energy, continued nausea.
Age: 83.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash macular, Tremor, Vaccination site pain, Vomiting
Clinical narrative: Vomiting (4), Diarrhea (6), headache, shaking, slight fever, rash blotches down my arm, red and sore vaccination site, fatigue (slept 36 hours), brain fog, no energy, continued nausea.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: fever and nausea.  It went away by 9:00 AM on May 6, 2021.  I feel great now.  Actually, it was not as bad as I was prepared.  My uncle had flu like symptoms from the same vaccine for 2 days.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness, Malaise, Pain
Clinical narrative: One day after: all over soreness and malaise similar to flu. Today, extreme tiredness.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation  (ex. different manufact. initial and booster)
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Asthenopia, Chills, Headache, Pain
Clinical narrative: 100.1F low grade fever, muscle soreness, chills, heavy eyes, headache, weakness, sore arm a day after second Pfizer dose. No symptoms after first dose.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: 100.1F low grade fever, muscle soreness, chills, heavy eyes, headache, weakness, sore arm a day after second Pfizer dose. No symptoms after first dose.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Hot flush
Clinical narrative: Constant pain in left wrist.  Wore a brace for a few days but the pain is still consistent. Major increase in daily hot flashes.  At the minimum, 3-5 during the course of the night and several during the day.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: tested positive for covid after receiving vaccine
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Biopsy endometrium, Postmenopausal haemorrhage, Ultrasound scan vagina, Uterine dilation and curettage
Clinical narrative: Pfizer 1st shot: 3/21     2nd shot: 4/11 Post-menapausal Bleeding  - started 3/27 - 4/9
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure normal, Body temperature normal, Chest pain, Dizziness, Dyspnoea
Clinical narrative: At 1210 pt  complained of feeling lightheaded, denied  shortness of breath, chest pain nausea or vomiting. Pt was taken to the triage site,  Vitals were obtained at 1213 T:36.9 BP:118/70, pulse 74 , O2:98 RR 20 pain:0. Provided water and laid patient down, pt verbalized feeling better. Denied any medical disorders, has eaten and well hydrated. At 1223 vitals were obtained T:37, P: 76, Bp: 118/74 pulse 76 O2 97 pain 0. Patient felt normal and left the center.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate normal, Nausea, Vital signs measurement, Vomiting
Clinical narrative: At 1210 pt  complained of feeling lightheaded, denied  shortness of breath, chest pain nausea or vomiting. Pt was taken to the triage site,  Vitals were obtained at 1213 T:36.9 BP:118/70, pulse 74 , O2:98 RR 20 pain:0. Provided water and laid patient down, pt verbalized feeling better. Denied any medical disorders, has eaten and well hydrated. At 1223 vitals were obtained T:37, P: 76, Bp: 118/74 pulse 76 O2 97 pain 0. Patient felt normal and left the center.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: UNKNOWN - Contact with and (suspected) exposure to covid-19
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Syncope
Clinical narrative: Client received her second dose of the Pfizer COVID-19 vaccine (Lot #EW0179 Exp. 8/2021) at 10:03 AM. EMT saw client stand in observation area. Client appeared "unsteady on her feet". EMT rushed to patient and guided her slowly to the ground while protecting her head. Patient then fainted. EMTs assisted patient to gravity bed where patient regained consciousness. Patient was alert and oriented to person, place, time, and event (AAO x 4) immediately following the incident. Client's vitals were assessed every 5 minutes. They were recorded as follows 10:19- Blood Pressure (BP) 100/74, Heart Rate (HR) 86, Oxygen Saturation (SPO2) 99%, and Respiratory Rate (RR) 18; 10:24- BP 100/72, HR 81, SPO2 99% RR 18; 10:29- BP 100/76, HR 82, SPO2 99% RR 16; 10:34- BP 102/74, HR 84, SPO2 99% RR 18; 10:39- BP 100/72, HR 82, SPO2 99% RR 18; 10:44- BP 110/76, HR 86, SPO2 99% RR 18. Client was given a bottle of water and instructed to remain in a semi-fowler's (45 degree) position until vitals stabilized. Patient remained on vaccination site for 30 minutes following the episode of fainting. EMT obtained orthostatic vital signs (vital trend from lying down, to sitting, to standing). Patient was negative for orthostatic hypotension. Symptoms resolved as indicated above in vital signs. Patient stated she was "feeling better" and declined EMS transport. Patient and father were educated by RN on home care (rest and fluids) and to seek emergency medical attention if symptoms persisted or worsened. Patient left the vaccination site at 10:45 with father and sister with steady gait and in no change in status.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Sensation of foreign body
Clinical narrative: Pt presents to ER from prompt care after having reaction to covid vaccine. Pt states he received first dose of Pfizer vaccine at 0930 and starting itching at approx 1010. Pt states he also feels like there is a pill stuck in his throat. Pt was given epinephrine at prompt care and then sent to emergency deparment for further evaluation and treatment. No swelling of tongue or lips noted.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation  (ex. different manufact. initial and booster)
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: COVID vaccine administration error to patient less than 18 years old Patient tolerated vaccine well.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Headache, Hypotension, Injection site bruising
Clinical narrative: Adverse Event: Hypotension BP 90/59; Pulse 170; Fever 101.1+ for 24hours; Severe Nausea; Severe Dizziness; Severe Headache;  Severe muscle and joint pain; Skin rash on neck and chest; Bruising and severe pain at injection site; Mild tussis Treatment: oral fluids; rest Outcome: Majority of symptoms resolved after 24 hours; remaining symptoms after 48 hours included: skin rash; mild dizziness; mild muscle and joint pain.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Myalgia, Nausea, Rash
Clinical narrative: Adverse Event: Hypotension BP 90/59; Pulse 170; Fever 101.1+ for 24hours; Severe Nausea; Severe Dizziness; Severe Headache;  Severe muscle and joint pain; Skin rash on neck and chest; Bruising and severe pain at injection site; Mild tussis Treatment: oral fluids; rest Outcome: Majority of symptoms resolved after 24 hours; remaining symptoms after 48 hours included: skin rash; mild dizziness; mild muscle and joint pain.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arteriosclerosis coronary artery, Back pain, Blood glucose increased, Catheterisation cardiac, Chest discomfort
Clinical narrative: Patient states shortly after getting the vaccine and alone in her apt her head began to hurt and her back aching. States her chest began feeling "funny" and she tried calling her daughter. With no answer she called the ambulance and was transported to ER. She was told upon arrival she was having a heart attack and transferred to cath lab. Blockages were found and 3 stents placed to right coronary artery.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Myocardial infarction, Stent placement
Clinical narrative: Patient states shortly after getting the vaccine and alone in her apt her head began to hurt and her back aching. States her chest began feeling "funny" and she tried calling her daughter. With no answer she called the ambulance and was transported to ER. She was told upon arrival she was having a heart attack and transferred to cath lab. Blockages were found and 3 stents placed to right coronary artery.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient received the 2nd Moderna dose 3 days early. No adverse events.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Bronchitis, COVID-19, SARS-CoV-2 test
Clinical narrative: Acute bronchitis due to 2019 novel coronavirus   predniSONE
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient is 17 years old.  Will reach out regarding 2nd dose if patient able to receive per CDC guidelines.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Injection site macule
Clinical narrative: Largest macule centered around L quad site of MMR vaccine delivery
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness
Clinical narrative: C/c of feeling dizziness/weakness after receiving her 2nd vaccine. Pt has Hx of Anxiety and takes prescribed Valium. V/S stable: BP: 120/78, HR: 78, SPO2: 98%RA. Pt stated that she did not want emergency called and did not want to go to the hospital.  Pt advised that taking an Uber was not recommended and emergency service would be called and that she is able to refuse transport thru emergency. They were called and arrived at 10:40. Pt was assessed and  refused transport. Pt signed Incident Report stating that she was refusing emergency transport and that she was claiming responsibility of being transported  home via Uber.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Incorrect dose administered, No adverse event
Clinical narrative: Patient came in with 2 other family members. Questions were all answered "no" on COVID vaccine consent form, and reviewed by writer.  Writer asked if patients had any questions. There were no questions. Vaccine was administered, and then the patient asked "Does this interact with the Johnson & Johnson Vaccine? We all got it about a month ago." They did not make this known until the vaccines were already administered. Writer contacted nurse for guidance. Told to report this as an incident, as the patients received two brands of vaccine. No adverse affects have been noted.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Confusional state, Dizziness, Flushing, Hyperhidrosis, Nausea
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Medium, Systemic: Seizure-Severe, Systemic: Vomiting-Medium, Additional Details: Patient began to seize/faint in chair within 5 minutes post-vaccination. Paramedics were called as I stabilized patient on floor. Consciousness regained within 60 seconds, patient confused/unaware of what had occured. Patient flush, lightheaded, vomiting. Paramedics arrived and confirmed patient was stable and safe to leave scene without further intervention.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Seizure, Syncope, Unresponsive to stimuli, Vomiting
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Medium, Systemic: Seizure-Severe, Systemic: Vomiting-Medium, Additional Details: Patient began to seize/faint in chair within 5 minutes post-vaccination. Paramedics were called as I stabilized patient on floor. Consciousness regained within 60 seconds, patient confused/unaware of what had occured. Patient flush, lightheaded, vomiting. Paramedics arrived and confirmed patient was stable and safe to leave scene without further intervention.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Patient states she received the Pfizer vaccine on 04/10/2021 and a week later developed shingles.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Culture urine, Epstein-Barr virus test positive, Full blood count, Haematuria, Metabolic function test
Clinical narrative: 4/23/2021 patient noted hematuria. Negative urine culture. + hematuria on dipstick. Tx with amoxil. Still having hematuria 5/3/2021. ASO titer POSITIVE. MOnospot POSITIVE and EBV panel positive.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Mononucleosis heterophile test positive, Streptococcus test, Urine analysis
Clinical narrative: 4/23/2021 patient noted hematuria. Negative urine culture. + hematuria on dipstick. Tx with amoxil. Still having hematuria 5/3/2021. ASO titer POSITIVE. MOnospot POSITIVE and EBV panel positive.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dysmenorrhoea, Headache, Heavy menstrual bleeding
Clinical narrative: Injection site tenderness, flu-like symptoms including headache, low grade fever, muscle and joint aches, chills, making work impossible for two days.  Intensely painful and heavy menstrual period a week later, including passing palm-sized blood clots and intense pain that did not subside with otc pain killers, TENS therapy or heat. Patient does not have a history of painful menstrual periods.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Impaired work ability, Influenza like illness, Injection site pain, Myalgia, Pyrexia
Clinical narrative: Injection site tenderness, flu-like symptoms including headache, low grade fever, muscle and joint aches, chills, making work impossible for two days.  Intensely painful and heavy menstrual period a week later, including passing palm-sized blood clots and intense pain that did not subside with otc pain killers, TENS therapy or heat. Patient does not have a history of painful menstrual periods.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Thrombosis
Clinical narrative: Injection site tenderness, flu-like symptoms including headache, low grade fever, muscle and joint aches, chills, making work impossible for two days.  Intensely painful and heavy menstrual period a week later, including passing palm-sized blood clots and intense pain that did not subside with otc pain killers, TENS therapy or heat. Patient does not have a history of painful menstrual periods.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Heart rate increased, Myocarditis, Scan myocardial perfusion abnormal, Troponin I normal
Clinical narrative: Patient developed fast heart rate, chest pain - seen by PMD who admitted patient to hospital cardiac scan showed Myocarditis. Symptoms started 5/1/21
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: Patient developed fast heart rate, chest pain - seen by PMD who admitted patient to hospital cardiac scan showed Myocarditis. Symptoms started 5/1/21
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Cold sweat, Dizziness, Immediate post-injection reaction, Pallor, Presyncope
Clinical narrative: CLIENT HAD A VASOVAGAL RESPONSE IMMEDIATELY AFTER GIVING HIS VACCINE. CLIENT BECAME CLAMMY, FAINT, DIZZY, AND VERY PALE AFTER THE INJECTION. CLIENT RECOVERED AFTER 30 MINUTES, WITH WATER AND ELIVATION OF THE FEET AND REST.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Syncope
Clinical narrative: CLIENT HAD A VASOVAGAL RESPONSE IMMEDIATELY AFTER GIVING HIS VACCINE. CLIENT BECAME CLAMMY, FAINT, DIZZY, AND VERY PALE AFTER THE INJECTION. CLIENT RECOVERED AFTER 30 MINUTES, WITH WATER AND ELIVATION OF THE FEET AND REST.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Burning sensation, Dizziness, Pain, Rash
Clinical narrative: Rash, blisters, burning sensation, dizziness, body aches
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient received the 2nd Moderna dose 3 days early. No adverse events.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: After about 10 minutes post-injection, patient started to get really dizzy.  He was helped from chair to the floor.  He never fully passed out but said he has gotten dizzy after traumatic events in the past.  The paramedic was already onsite and monitored him for next 15 minutes until he felt better and was stable.  He left feeling fine.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Throat tightness
Clinical narrative: After administering the Janssen vaccine the patient began to have dizziness and difficulty breathing. The patient's airway did not completely close up as he was able to respond and talk to me. Called 911 and administered 10mL (25mg) of Diphenhydramine and gave the patient a bottle of water. He was already worked up as he was scared of needles. He continued to breath better but still had difficulty. The EMT arrived in under 5 minutes as they were already on a call close by and was rerouted. EMT administered breathing treatment and took vitals and eventually took the patient to the hospital as a precaution. (Technician administered vaccine)
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Lymphadenopathy, Rash, Rash pruritic
Clinical narrative: RASH DEVELOPED ON TORSO/SIDES OF NECK/EARS ON 4/9 THRU 4/13--ITCHY AT END OF COURSE. ALSO SWOLLEN LYMPH NODES RESULTING IN BRUISING
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenitis, Lymphadenopathy
Clinical narrative: Swelling under the armpit and area is tender and somewhat sore
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: patient was underage at the time of receiving covid 19 moderna. patients parents approved for patient to get dose 2
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Fatigue, Headache, Injection site pruritus, Injection site swelling
Clinical narrative: 3 hours after shot, experienced headache, fatigue and general aches and pains. last 24 hours 7 days after shot, experienced "covid arm" - raised, red, swollen, hot, slight itch large area around shot.  cleared after 3 days 20 days after shot, area of "covid arm' is now a bruse. Does not hurt, but is noticeable. still have it at 27 days
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Pain, Vaccination complication
Clinical narrative: 3 hours after shot, experienced headache, fatigue and general aches and pains. last 24 hours 7 days after shot, experienced "covid arm" - raised, red, swollen, hot, slight itch large area around shot.  cleared after 3 days 20 days after shot, area of "covid arm' is now a bruse. Does not hurt, but is noticeable. still have it at 27 days
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Myalgia, Nasal congestion, Oropharyngeal pain, Pain
Clinical narrative: COUGH, Muscle or body aches ,sore throat,sinus ,stuffy nose    Pt recently received her COVID Vaccine #1 on 1/11/21
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: COUGH, Muscle or body aches ,sore throat,sinus ,stuffy nose    Pt recently received her COVID Vaccine #1 on 1/11/21
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: pt woke this morning feeling like his right arm, his ring finger, and pinky is having the circulation is being cut off.   He has had this strange constant numb, tingling, and pain from this that he has had all day.  He is having trouble concentrating and has brain fog today.  He will contact his PCP if symptoms worsen.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Error: Diluent Administered Instead of Vaccine
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: After receiving the vaccine, pt felt lightheaded, dizzy, and slightly nauseaous. He did not have an irregular H/R or breaths and did not eat today.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nasal congestion, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: Nasal congestion   Rhinorrhea   Acute nonintractable headache, unspecified headache type  Stay hydrated by drinking plenty of fluids.  Use tylenol or ibuprofen per manufacturer's instructions for fever or pain control.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance, Joint swelling, Mobility decreased
Clinical narrative: "Moderna COVID-19 Vaccine EUA"  After I took the Moderna vaccine there was swelling and pain in my left knee. The swelling makes it difficult to walk and bend at that knee.
Age: 35.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: First dose was Pfizer.  No adverse effects noted during initial observation period.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Abortion spontaneous, Chills, Cytogenetic abnormality, Exposure during pregnancy, Fatigue
Clinical narrative: The day after the vaccine I had a headache, chills and fatigue for the whole day. The following day I felt normal. Five days after the vaccine I had a silent miscarriage  and I was diagnosed on 04/19/2021. The doctor identified 04/10/2021 as the day that the fetus was no longer viable. I was in my seventh week.  The Pathology returned identifying Chromosomal abnormality.  Due Date-11/21/2021 First Pregnancy
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Primigravida, Ultrasound scan
Clinical narrative: The day after the vaccine I had a headache, chills and fatigue for the whole day. The following day I felt normal. Five days after the vaccine I had a silent miscarriage  and I was diagnosed on 04/19/2021. The doctor identified 04/10/2021 as the day that the fetus was no longer viable. I was in my seventh week.  The Pathology returned identifying Chromosomal abnormality.  Due Date-11/21/2021 First Pregnancy
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer increased
Clinical narrative: Elevated D dimer
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Cerebral venous sinus thrombosis, Computerised tomogram head abnormal, Headache, Hemianopia homonymous
Clinical narrative: Patient got her second dose of the Pfizer vaccine on 4/20 and started to feel a headache come on and believed it was due to a migraine. On 5/1 she went to her local ED and was given migraine treatment. She continued to have worse headaches and developed subsequent L homonomous hemianopsia, L sided weakness, and L sided neglect. She presented to the ED on 5/5 and was found to have cerebral venous sinus thrombosis confirmed by head CT. Other risk factors include active COVID-19 infection (unknown at time of vaccine administration) and OCP usage.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hemiparesis, Laboratory test normal, Neurologic neglect syndrome
Clinical narrative: Patient got her second dose of the Pfizer vaccine on 4/20 and started to feel a headache come on and believed it was due to a migraine. On 5/1 she went to her local ED and was given migraine treatment. She continued to have worse headaches and developed subsequent L homonomous hemianopsia, L sided weakness, and L sided neglect. She presented to the ED on 5/5 and was found to have cerebral venous sinus thrombosis confirmed by head CT. Other risk factors include active COVID-19 infection (unknown at time of vaccine administration) and OCP usage.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cerebral venous sinus thrombosis, Computerised tomogram head abnormal, Condition aggravated, Encephalopathy, Haemorrhagic transformation stroke
Clinical narrative: Patient got her second dose of the Pfizer vaccine on 4/20 and started to feel a headache come on and believed it was due to a migraine. On 5/1 she went to her local ED and was given migraine treatment. She continued to have worse headaches and developed subsequent L homonomous hemianopsia, L sided weakness, and L sided neglect. She presented to the ED on 5/5 and was found to have cerebral venous sinus thrombosis confirmed by head CT. Other risk factors include active COVID-19 infection (unknown at time of vaccine administration) and OCP usage.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Magnetic resonance imaging head, Muscular weakness, Paraesthesia
Clinical narrative: Patient got her second dose of the Pfizer vaccine on 4/20 and started to feel a headache come on and believed it was due to a migraine. On 5/1 she went to her local ED and was given migraine treatment. She continued to have worse headaches and developed subsequent L homonomous hemianopsia, L sided weakness, and L sided neglect. She presented to the ED on 5/5 and was found to have cerebral venous sinus thrombosis confirmed by head CT. Other risk factors include active COVID-19 infection (unknown at time of vaccine administration) and OCP usage.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cerebral venous sinus thrombosis, Computerised tomogram head abnormal, Confusional state, Headache, Hemianopia homonymous
Clinical narrative: Patient got her second dose of the Pfizer vaccine on 4/20 and started to feel a headache come on and believed it was due to a migraine. On 5/1 she went to her local ED and was given migraine treatment. She continued to have worse headaches and developed subsequent L homonomous hemianopsia, L sided weakness, and L sided neglect. She presented to the ED on 5/5 and was found to have cerebral venous sinus thrombosis confirmed by head CT. Other risk factors include active COVID-19 infection (unknown at time of vaccine administration) and OCP usage.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hemiparesis, Intensive care, Migraine, Seizure
Clinical narrative: Patient got her second dose of the Pfizer vaccine on 4/20 and started to feel a headache come on and believed it was due to a migraine. On 5/1 she went to her local ED and was given migraine treatment. She continued to have worse headaches and developed subsequent L homonomous hemianopsia, L sided weakness, and L sided neglect. She presented to the ED on 5/5 and was found to have cerebral venous sinus thrombosis confirmed by head CT. Other risk factors include active COVID-19 infection (unknown at time of vaccine administration) and OCP usage.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Myalgia, Nausea
Clinical narrative: Dizziness, head ache, malagia,nausea
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient received the 2nd Moderna dose 3 days early. No adverse events.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Asthenia, Blood lactic acid, Blood test, Coagulation test
Clinical narrative: Patient tolerated Covid vaccine well. Directed to sit in observation area post. After approximately 10 minutes, she felt weak and approached the Vaccine reception desk and c/o weakness, fatigue, and belly pain. RN brought patient back and assessed VS: 50/40, extremely hypotensive. Brought via WC to room with stretcher. Auto VS: 50/38, 98% @ 10:10am.  MD arrived. EKG performed was wnl, IV #20g inserted by IV RN LAC,  Cbc, cmp, T&S, Coags drawn, 1000cc NS bolus started wide open. EMS called. VS improved only slightly. Patient c/o of belly pain, was able to make needs known, responding in full sentences, alert & oriented. EMS arrived, slid to stretcher, as payient c/o of continued weakness. At 10:40am EMS took patient to hospital, as requested by MD.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram normal, Fatigue, Full blood count, Metabolic function test
Clinical narrative: Patient tolerated Covid vaccine well. Directed to sit in observation area post. After approximately 10 minutes, she felt weak and approached the Vaccine reception desk and c/o weakness, fatigue, and belly pain. RN brought patient back and assessed VS: 50/40, extremely hypotensive. Brought via WC to room with stretcher. Auto VS: 50/38, 98% @ 10:10am.  MD arrived. EKG performed was wnl, IV #20g inserted by IV RN LAC,  Cbc, cmp, T&S, Coags drawn, 1000cc NS bolus started wide open. EMS called. VS improved only slightly. Patient c/o of belly pain, was able to make needs known, responding in full sentences, alert & oriented. EMS arrived, slid to stretcher, as payient c/o of continued weakness. At 10:40am EMS took patient to hospital, as requested by MD.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Activated partial thromboplastin time, Product preparation issue
Clinical narrative: Error: Diluent Administered Instead of Vaccine
Age: 67.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: She received Prevnar #13 on 4/27/21 in our office. Given into right deltoid.  Four days later she noticed redness on right deltoid. It was itchy. Still red and swollen. Swelling was worse. Treatment: ice pack, Hydrocortisone ointment
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Aggression, Blood culture, Blood test normal, Chest X-ray, Computerised tomogram head normal
Clinical narrative: 3 days post vaccination resident had increase confusion, new hallucinations, combative behavior. UA, blood work, CT of head, negative for acute findings, Hospital stay x 2 occurrences, including psychiatric evaluation. Follow up with neurologist pending .
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Confusional state, Full blood count, Hallucination, Magnetic resonance imaging head, Metabolic function test
Clinical narrative: 3 days post vaccination resident had increase confusion, new hallucinations, combative behavior. UA, blood work, CT of head, negative for acute findings, Hospital stay x 2 occurrences, including psychiatric evaluation. Follow up with neurologist pending .
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Urine analysis normal
Clinical narrative: 3 days post vaccination resident had increase confusion, new hallucinations, combative behavior. UA, blood work, CT of head, negative for acute findings, Hospital stay x 2 occurrences, including psychiatric evaluation. Follow up with neurologist pending .
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy skin abnormal, Erythema, Immunology test, Peripheral swelling, Rash
Clinical narrative: Patient was treated on 3/10/21 w/ 3 days of Bactrim for UTI. First COVID vaccine 3/18/21, that day developed redness and swelling of face, low back, chest, feet. Rash is persistent to this date with no imprvovement. She had bloodwork to rule out, RA, Lyme, thyroid disease all within normal limits. Skin biopsy was done 4/1/21 which showed likely hypersensitivity reaction to drug or ssytemic allergic versus a connective tissue disease.  Stains that were done argue against Lupus.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Rheumatoid factor negative, Swelling, Swelling face, Thyroid function test, Urinary tract infection
Clinical narrative: Patient was treated on 3/10/21 w/ 3 days of Bactrim for UTI. First COVID vaccine 3/18/21, that day developed redness and swelling of face, low back, chest, feet. Rash is persistent to this date with no imprvovement. She had bloodwork to rule out, RA, Lyme, thyroid disease all within normal limits. Skin biopsy was done 4/1/21 which showed likely hypersensitivity reaction to drug or ssytemic allergic versus a connective tissue disease.  Stains that were done argue against Lupus.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site mass, Injection site pain, Injection site pruritus, Rash, Rash pruritic
Clinical narrative: Experienced the arm pain around the injection site for about 4-5 days. By day 7, a lump formed at the injection site and it was itchy. By day 8, my arm broke out in a itchy rash from my shoulder bone down my arm to just above my elbow. I used over the counter hydrocortisone topical cream to stop the itchiness. The rash went away in 5 days.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Blood creatine phosphokinase increased, Gait inability, Urinary incontinence
Clinical narrative: Pt had dose 1 Moderna on 5/3 within 24 hours had back pain and urinary incontinence unable to ambulate. Hospitalized overnight.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Error: Diluent Administered Instead of Vaccine
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Impaired quality of life, Sleep disorder, Tinnitus
Clinical narrative: Gradual onset tinnitus in left ear over the following 48 hours after the vaccine, worsening to current level over about 7 days. Has been constant since then. The level is moderate and interferes somewhat with sleep and quality of life. Also headaches on that side. No treatment has been attempted as of yet.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was underage when we gave her Covid 19 Moderna dose 2. She received dose 1 in center
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Heart rate increased, Throat tightness
Clinical narrative: after the second covid dose, patient reported that she felt that her throat is closing. observed her for a few minutes and called 911. Emergency management services examined her and told her that her breathing  is ok and heartrate little high because she was looking anxious . but she insisted her throat is closing. Ambulance took her to the emergency room . She called the pharmacy after 4 hours and said that she was treated with allergy medication in the ER.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Fatigue, Feeling abnormal, Headache, Rash
Clinical narrative: nose bleed for 45 minutes day of (25 minutes after shot) fatigue brain fog Bad headache that lasted days (still have it while filling out this report 3 days later) rashes in random places all over my body develped 2 days later
Age: 74.0
Sex: U
Vaccine: COVID19
Symptoms: Blood brain barrier defect, Bradycardia, Cerebral atrophy, Cerebrovascular accident, Computerised tomogram abnormal
Clinical narrative: Patient is a 74 y/o female with PMH significant for meningitis at age 2 resulting in developmental delay (non-verbal at baseline and seizure disorder) who presented for poor oral intake, dysphagia, and inability walk due to increased lower extremity weakness that has been occurring since April 9th. The patient is typically ambulatory but needs significant assistance with ADLs. She is able to feed herself (tends to eat baby food). Eventually, the patient was admitted for sepsis 2/2 UTI and now with concerns for remote stroke with persistent dysphagia and acute encephalopathy.   Since April 9th, the family has noted that the patient has had difficulty swallowing baby food and seems to be uncomfortable; she is able to make a couple of audible sounds or gestures that suggest pain and that is why they brought her. The family also reports that the patient received her second dose of the Pfizer-BioNTech COVID-19 vaccine on 04/07/2021.   On 04/08/2021, the patient had one staring episode, but then returned to baseline. She was at baseline during breakfast on the morning on 04/09/2021, but around lunchtime, she had another staring spell and was unable to swallow food as well as unable to walk, stand, or move her lower extremities. The patient has limited language at baseline but also has not been able to say the few words she used to communicate with her family, only moaning and grunting since that time. Since 04/09, she has not been able to consume any solid foods, only eating a very small amount of smashed/liquified fruit and drinking Pedialyte. Sister has been massaging her legs regularly in hopes of re-establishing movement but saw nothing until yesterday (05/05/2021) when the patient moved toes bilaterally and briefly lifted her right leg.    Neurology Consult on 05/05/2021:  The patient had mildly bradycardiac and hypertensive (170s/80s). Labs reviewed and showed mildly elevated WBC (i.e., 12.9 K/MM3) and urinalysis was consistent with UTI.  Imaging was reviewed and consistent with chronic CVA, likely occurring on 04/09/2021 while the patient was in hypercoagulable post-COVID vaccine state.   Neurology recommends CT angio head and neck, TTE w/ bubble, A1c, fasting lipid panel, DVT prophylaxis via lovenox 40mg SC daily, D-dimer levels, EKG, PT/OT?Speech therapy evals, BP control via lisinopril 10mg daily w/ goal of < 140/90, and ASA 81mg daily
Age: 74.0
Sex: U
Vaccine: COVID19
Symptoms: Condition aggravated, Discomfort, Dysphagia, Dysstasia, Fibrin D dimer
Clinical narrative: Patient is a 74 y/o female with PMH significant for meningitis at age 2 resulting in developmental delay (non-verbal at baseline and seizure disorder) who presented for poor oral intake, dysphagia, and inability walk due to increased lower extremity weakness that has been occurring since April 9th. The patient is typically ambulatory but needs significant assistance with ADLs. She is able to feed herself (tends to eat baby food). Eventually, the patient was admitted for sepsis 2/2 UTI and now with concerns for remote stroke with persistent dysphagia and acute encephalopathy.   Since April 9th, the family has noted that the patient has had difficulty swallowing baby food and seems to be uncomfortable; she is able to make a couple of audible sounds or gestures that suggest pain and that is why they brought her. The family also reports that the patient received her second dose of the Pfizer-BioNTech COVID-19 vaccine on 04/07/2021.   On 04/08/2021, the patient had one staring episode, but then returned to baseline. She was at baseline during breakfast on the morning on 04/09/2021, but around lunchtime, she had another staring spell and was unable to swallow food as well as unable to walk, stand, or move her lower extremities. The patient has limited language at baseline but also has not been able to say the few words she used to communicate with her family, only moaning and grunting since that time. Since 04/09, she has not been able to consume any solid foods, only eating a very small amount of smashed/liquified fruit and drinking Pedialyte. Sister has been massaging her legs regularly in hopes of re-establishing movement but saw nothing until yesterday (05/05/2021) when the patient moved toes bilaterally and briefly lifted her right leg.    Neurology Consult on 05/05/2021:  The patient had mildly bradycardiac and hypertensive (170s/80s). Labs reviewed and showed mildly elevated WBC (i.e., 12.9 K/MM3) and urinalysis was consistent with UTI.  Imaging was reviewed and consistent with chronic CVA, likely occurring on 04/09/2021 while the patient was in hypercoagulable post-COVID vaccine state.   Neurology recommends CT angio head and neck, TTE w/ bubble, A1c, fasting lipid panel, DVT prophylaxis via lovenox 40mg SC daily, D-dimer levels, EKG, PT/OT?Speech therapy evals, BP control via lisinopril 10mg daily w/ goal of < 140/90, and ASA 81mg daily
Age: 74.0
Sex: U
Vaccine: COVID19
Symptoms: Gait inability, Haemorrhagic transformation stroke, Hypercoagulation, Hypertension, Hypophagia
Clinical narrative: Patient is a 74 y/o female with PMH significant for meningitis at age 2 resulting in developmental delay (non-verbal at baseline and seizure disorder) who presented for poor oral intake, dysphagia, and inability walk due to increased lower extremity weakness that has been occurring since April 9th. The patient is typically ambulatory but needs significant assistance with ADLs. She is able to feed herself (tends to eat baby food). Eventually, the patient was admitted for sepsis 2/2 UTI and now with concerns for remote stroke with persistent dysphagia and acute encephalopathy.   Since April 9th, the family has noted that the patient has had difficulty swallowing baby food and seems to be uncomfortable; she is able to make a couple of audible sounds or gestures that suggest pain and that is why they brought her. The family also reports that the patient received her second dose of the Pfizer-BioNTech COVID-19 vaccine on 04/07/2021.   On 04/08/2021, the patient had one staring episode, but then returned to baseline. She was at baseline during breakfast on the morning on 04/09/2021, but around lunchtime, she had another staring spell and was unable to swallow food as well as unable to walk, stand, or move her lower extremities. The patient has limited language at baseline but also has not been able to say the few words she used to communicate with her family, only moaning and grunting since that time. Since 04/09, she has not been able to consume any solid foods, only eating a very small amount of smashed/liquified fruit and drinking Pedialyte. Sister has been massaging her legs regularly in hopes of re-establishing movement but saw nothing until yesterday (05/05/2021) when the patient moved toes bilaterally and briefly lifted her right leg.    Neurology Consult on 05/05/2021:  The patient had mildly bradycardiac and hypertensive (170s/80s). Labs reviewed and showed mildly elevated WBC (i.e., 12.9 K/MM3) and urinalysis was consistent with UTI.  Imaging was reviewed and consistent with chronic CVA, likely occurring on 04/09/2021 while the patient was in hypercoagulable post-COVID vaccine state.   Neurology recommends CT angio head and neck, TTE w/ bubble, A1c, fasting lipid panel, DVT prophylaxis via lovenox 40mg SC daily, D-dimer levels, EKG, PT/OT?Speech therapy evals, BP control via lisinopril 10mg daily w/ goal of < 140/90, and ASA 81mg daily
Age: 74.0
Sex: U
Vaccine: COVID19
Symptoms: Magnetic resonance imaging, Magnetic resonance imaging abnormal, Muscular weakness, Paralysis, Sepsis
Clinical narrative: Patient is a 74 y/o female with PMH significant for meningitis at age 2 resulting in developmental delay (non-verbal at baseline and seizure disorder) who presented for poor oral intake, dysphagia, and inability walk due to increased lower extremity weakness that has been occurring since April 9th. The patient is typically ambulatory but needs significant assistance with ADLs. She is able to feed herself (tends to eat baby food). Eventually, the patient was admitted for sepsis 2/2 UTI and now with concerns for remote stroke with persistent dysphagia and acute encephalopathy.   Since April 9th, the family has noted that the patient has had difficulty swallowing baby food and seems to be uncomfortable; she is able to make a couple of audible sounds or gestures that suggest pain and that is why they brought her. The family also reports that the patient received her second dose of the Pfizer-BioNTech COVID-19 vaccine on 04/07/2021.   On 04/08/2021, the patient had one staring episode, but then returned to baseline. She was at baseline during breakfast on the morning on 04/09/2021, but around lunchtime, she had another staring spell and was unable to swallow food as well as unable to walk, stand, or move her lower extremities. The patient has limited language at baseline but also has not been able to say the few words she used to communicate with her family, only moaning and grunting since that time. Since 04/09, she has not been able to consume any solid foods, only eating a very small amount of smashed/liquified fruit and drinking Pedialyte. Sister has been massaging her legs regularly in hopes of re-establishing movement but saw nothing until yesterday (05/05/2021) when the patient moved toes bilaterally and briefly lifted her right leg.    Neurology Consult on 05/05/2021:  The patient had mildly bradycardiac and hypertensive (170s/80s). Labs reviewed and showed mildly elevated WBC (i.e., 12.9 K/MM3) and urinalysis was consistent with UTI.  Imaging was reviewed and consistent with chronic CVA, likely occurring on 04/09/2021 while the patient was in hypercoagulable post-COVID vaccine state.   Neurology recommends CT angio head and neck, TTE w/ bubble, A1c, fasting lipid panel, DVT prophylaxis via lovenox 40mg SC daily, D-dimer levels, EKG, PT/OT?Speech therapy evals, BP control via lisinopril 10mg daily w/ goal of < 140/90, and ASA 81mg daily